p.89 抽出テキスト

592. Fernandez-Hidalgo N, Almirante B, Tornos P, Gonzalez-Alujas MT, Planes AM, Galinanes M, et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect 2012;18:E522–E530. https://doi.org/10.1111/1469-0691.12033 593. Scheggi V, Merilli I, Marcucci R, Del Pace S, Olivotto I, Zoppetti N, et al. Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre. BMC Cardiovasc Disord 2021;21:28. https://doi. org/10.1186/s12872-021-01853-6 594. Yoshioka D, Toda K, Yokoyama JY, Matsuura R, Miyagawa S, Kainuma S, et al. Diabetes mellitus adversely affects mortality and recurrence after valve surgery for infective endocarditis. J Thorac Cardiovasc Surg 2018;155:1021–1029.e5. https://doi.org/10. 1016/j.jtcvs.2017.09.013 595. Citro R, Chan KL, Miglioranza MH, Laroche C, Benvenga RM, Furnaz S, et al. Clinical profile and outcome of recurrent infective endocarditis. Heart 2022;108: 1729–1736. https://doi.org/10.1136/heartjnl-2021-320652 596. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, Singh RK, et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis 2005;41:406–409. https://doi.org/10.1086/431590 597. Inagaki K, Lucar J, Blackshear C, Hobbs CV. Methicillin-susceptible and methicillinresistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis 2019;69:2112–2118. https://doi.org/10.1093/cid/ciz123 598. David TE, Gavra G, Feindel CM, Regesta T, Armstrong S, Maganti MD. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg 2007;133:144–9. https://doi.org/10.1016/j.jtcvs.2006.08.060 599. Fedoruk LM, Jamieson WR, Ling H, Macnab JS, Germann E, Karim SS, et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg 2009;137: 326–333. https://doi.org/10.1016/j.jtcvs.2008.08.024 600. Moon MR, Miller DC, Moore KA, Oyer PE, Mitchell RS, Robbins RC, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 2001;71:1164–1171. https://doi.org/10.1016/S0003-4975(00) 02665-5 601. Toyoda N, Itagaki S, Tannous H, Egorova NN, Chikwe J. Bioprosthetic versus mechanical valve replacement for infective endocarditis: focus on recurrence rates. Ann Thorac Surg 2018;106:99–106. https://doi.org/10.1016/j.athoracsur.2017.12.046 602. Ostergaard L, Dahl A, Fosbol E, Bruun NE, Oestergaard LB, Lauridsen TK, et al. Residual vegetation after treatment for left-sided infective endocarditis and subsequent risk of stroke and recurrence of endocarditis. Int J Cardiol 2019;293:67–72. https://doi.org/10.1016/j.ijcard.2019.06.059 603. Rasmussen TB, Zwisler AD, Moons P, Berg SK. Insufficient living: experiences of recovery after infective endocarditis. J Cardiovasc Nurs 2015;30:E11–E19. https://doi.org/10. 1097/JCN.0000000000000144 604. Rasmussen TB, Zwisler AD, Thygesen LC, Bundgaard H, Moons P, Berg SK. High readmission rates and mental distress after infective endocarditis – results from the national population-based CopenHeart IE survey. Int J Cardiol 2017;235:133–140. https:// doi.org/10.1016/j.ijcard.2017.02.077 605. Rasmussen TB, Zwisler AD, Risom SS, Sibilitz KL, Christensen J, Bundgaard H, et al. Comprehensive cardiac rehabilitation for patients following infective endocarditis: results of the randomized CopenHeartIE trial. Eur J Cardiovasc Nurs 2022;21:261–270. https://doi.org/10.1093/eurjcn/zvab047 606. Price CN, Solomon DA, Johnson JA, Montgomery MW, Martin B, Suzuki J. Feasibility and safety of outpatient parenteral antimicrobial therapy in conjunction with addiction treatment for people who inject drugs. J Infect Dis 2020;222(Suppl 5):S494–S498. https://doi.org/10.1093/infdis/jiaa025 607. Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D, et al. Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis. JAMA Netw Open 2020;3: e2016228. https://doi.org/10.1001/jamanetworkopen.2020.16228 608. Hays LH. Infective endocarditis: call for education of adults with CHD: review of the evidence. Cardiol Young 2016;26:426–430. https://doi.org/10.1017/S104795111500 2395 609. Abraham LN, Sibilitz KL, Berg SK, Tang LH, Risom SS, Lindschou J, et al. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev 2021;5:CD010876. https://doi.org/10.1002/14651858.CD010876.pub3 610. Abegaz TM, Bhagavathula AS, Gebreyohannes EA, Mekonnen AB, Abebe TB. Shortand long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017;17:291. https://doi.org/10.1186/s12872- 017-0729-5 611. Ternhag A, Cederstrom A, Torner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One 2013; 8:e67519. https://doi.org/10.1371/journal.pone.0067519 612. Collonnaz M, Erpelding ML, Alla F, Goehringer F, Delahaye F, Iung B, et al. Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditis. Ann Epidemiol 2021;54:29–37. https://doi.org/10.1016/ j.annepidem.2020.09.008 613. Mokhles MM, Ciampichetti I, Head SJ, Takkenberg JJ, Bogers AJ. Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg 2011;91:1407–1412. https://doi.org/10.1016/j.athoracsur.2011.02.007 614. Straw S, Baig MW, Gillott R, Wu J, Witte KK, O’Regan DJ, et al. Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery. Clin Infect Dis 2020;71:564–571. https://doi.org/10.1093/cid/ciz869 615. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335: 407–416. https://doi.org/10.1056/NEJM199608083350607 616. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139–149. https://doi.org/ 10.1016/S0140-6736(03)15266-X 617. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002;288:75–81. https://doi.org/10.1001/jama.288.1.75 618. Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year populationbased survey. Clin Infect Dis 2012;54:1230–1239. https://doi.org/10.1093/cid/cis199 619. Anantha Narayanan M, Mahfood Haddad T, Kalil AC, Kanmanthareddy A, Suri RM, Mansour G, et al. Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis. Heart 2016;102: 950–957. https://doi.org/10.1136/heartjnl-2015-308589 620. Brennan JM, Edwards FH, Zhao Y, O’Brien S, Booth ME, Dokholyan RS, et al. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons adult cardiac surgery national database. Circulation 2013;127:1647–1655. https://doi.org/10.1161/ CIRCULATIONAHA.113.002003 621. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Pare C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007;297: 1354–1361. https://doi.org/10.1001/jama.297.12.1354 622. Lopez J, Revilla A, Vilacosta I, Villacorta E, Gonzalez-Juanatey C, Gomez I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J 2007;28:760–765. https://doi. org/10.1093/eurheartj/ehl486 623. Moriyama N, Laakso T, Biancari F, Raivio P, Jalava MP, Jaakkola J, et al. Prosthetic valve endocarditis after transcatheter or surgical aortic valve replacement with a bioprosthesis: results from the FinnValve registry. EuroIntervention 2019;15:e500–e507. https:// doi.org/10.4244/EIJ-D-19-00247 624. Berisha B, Ragnarsson S, Olaison L, Rasmussen M. Microbiological etiology in prosthetic valve endocarditis: a nationwide registry study. J Intern Med 2022;292:428–437. https://doi.org/10.1111/joim.13491 625. Kohler P, Kuster SP, Bloemberg G, Schulthess B, Frank M, Tanner FC, et al. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J 2015;36:2745–2753. https://doi.org/10.1093/eurheartj/ehv342 626. Chamat-Hedemand S, Dahl A, Ostergaard L, Arpi M, Fosbol E, Boel J, et al. Prevalence of infective endocarditis in streptococcal bloodstream infections is dependent on streptococcal species. Circulation 2020;142:720–730. https://doi.org/10.1161/ CIRCULATIONAHA.120.046723 627. Expert Panel on Cardiac Imaging; Malik SB, Hsu JY, Hurwitz Koweek LM, Ghoshhajra BB, Beache GM, et al. ACR appropriateness criteria(r) infective endocarditis. J Am Coll Radiol 2021;18:S52–S61. https://doi.org/10.1016/j.jacr.2021.01.010 628. Luciani N, Mossuto E, Ricci D, Luciani M, Russo M, Salsano A, et al. Prosthetic valve endocarditis: predictors of early outcome of surgical therapy. A multicentric study. Eur J Cardiothorac Surg 2017;52:768–774. https://doi.org/10.1093/ejcts/ezx169 629. Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Prosthetic valve endocarditis after surgical aortic valve replacement. Circulation 2017;136:329–331. https://doi.org/10.1161/CIRCULATIONAHA.117.028783 630. Erdem H, Puca E, Ruch Y, Santos L, Ghanem-Zoubi N, Argemi X, et al. Portraying infective endocarditis: results of multinational ID-IRI study. Eur J Clin Microbiol Infect Dis 2019;38:1753–1763. https://doi.org/10.1007/s10096-019-03607-x 631. Shrestha NK, Shah SY, Hussain ST, Pettersson GB, Griffin BP, Nowacki AS, et al. Association of surgical treatment with survival in patients with prosthetic valve endocarditis. Ann Thorac Surg 2020;109:1834–1843. https://doi.org/10.1016/j.athoracsur. 2019.09.015 632. Truninger K, Attenhofer Jost CH, Seifert B, Vogt PR, Follath F, Schaffner A, et al. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart 1999;82:714–720. https:// doi.org/10.1136/hrt.82.6.714 633. Tornos P, Almirante B, Olona M, Permanyer G, Gonzalez T, Carballo J, et al. Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis 1997;24:381–386. https://doi.org/10.1093/clinids/24.3.381 634. Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E, Miro JM, et al. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother 2015;59:2365–2373. https://doi.org/10.1128/AAC.04867-14 635. Castillo JC, Anguita MP, Torres F, Mesa D, Franco M, Gonzalez E, et al. Long-term prognosis of early and late prosthetic valve endocarditis. Am J Cardiol 2004;93: 1185–1187. https://doi.org/10.1016/j.amjcard.2004.01.056 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026